FT

US approves resumption of J&J’s Covid-19 vaccine

Regulators conclude benefits of the single-shot jab outweigh the risk of rare blood clots

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button